journal
MENU ▼
Read by QxMD icon Read
search

Pharmaceutical Patent Analyst

journal
https://www.readbyqxmd.com/read/28343406/corrigendum
#1
(no author information available yet)
No abstract text is available yet for this article.
March 27, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28274178/the-consequences-of-double-examination-for-pharmaceutical-patent-applications-in-brazil
#2
Gabriela Salerno
No abstract text is available yet for this article.
March 9, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28248129/key-points-of-the-new-spanish-patent-act
#3
Teresa Mercadal Menchaca
No abstract text is available yet for this article.
March 1, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28201948/enbrel-and-etanercept-biosimilars-a-tale-of-two-patent-systems
#4
Peter Norman
No abstract text is available yet for this article.
February 16, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28198642/upcoming-challenges-in-intellectural-property-presented-by-emerging-pharmaceutical-technologies
#5
Takeshi S Komatani
No abstract text is available yet for this article.
February 15, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28181455/how-cuozzo-will-impact-the-interplay-between-post-grant-proceedings-and-hatch-waxman-litigation
#6
Natasha Mishra, Patrick A Doody, Raj S Davé
No abstract text is available yet for this article.
February 9, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28155570/pharmaceutical-patent-protection-the-united-states-and-japan-in-comparative-perspective
#7
Shinya Kimura, Carlyn A Burton
No abstract text is available yet for this article.
February 3, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28248151/p2x7-antagonists-for-cns-indications-recent-patent-disclosures
#8
REVIEW
Paolo Pevarello, Silvia Bovolenta, Paola Tarroni, Lorena Za, Elda Severi, Domenica Torino, Rocco Vitalone
P2X7, a ligand-gated purinergic ion channel, has been at the center of intense efforts in the pharmaceutical industry in the last 15 years due to the growing appreciation of its role in inflammation. Since 2008-2009, increased focus on CNS available compounds has led to the publication of various patents on behalf of several pharmaceutical companies. This patent review aims at analyzing the recent patent literature (2008-2016) with a particular emphasis on those patents that are thought to deal with CNS penetrant compounds on the basis of their physicochemical features, the assays described in the patents and the uses these compounds are claimed for...
March 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28248128/patent-highlights-october-november-2016
#9
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
March 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28248125/drug-delivery-via-porous-silicon-a-focused-patent-review
#10
REVIEW
Paulina A Kulyavtsev, Roxanne P Spencer
Although silicon is more commonly associated with computer chips than with drug delivery, with the discovery that porous silicon is a viable biocompatible material, mesoporous silicon with pores between 2 and 50 nm has been loaded with small molecule and biomolecule therapeutics and safely implanted for controlled release. As porous silicon is readily oxidized, porous silica must also be considered for drug delivery applications. Since 2010, only a limited number of US patents have been granted, primarily for ophthalmologic and immunotherapy applications, in contrast to the growing body of technical literature in this area...
March 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28155581/patent-highlights-august-september-2016
#11
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
January 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28155578/novel-linkers-and-connections-for-antibody-drug-conjugates-to-treat-cancer-and-infectious-disease
#12
Thomas H Pillow
Antibody-drug conjugates (ADCs) are an exciting therapeutic, combining the extreme potency of a small molecule cytotoxic drug with the exquisite selectivity of a monoclonal antibody. Despite the promising concept and many decades of research and clinical experiments, only two ADCs are approved for human use. Among the lessons learned, have been the need for highly stable and potentially releasable linkers and the empirical nature of therapeutic index supporting the testing of many diverse cytotoxics, many requiring new linker connections for the drug's available functional groups...
January 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27848274/is-inherent-disclosure-sufficient-for-priority-claim-monoclonal-versus-chimeric-humanized-antibody-estoppels
#13
Takeshi S Komatani
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27813447/fostering-innovative-product-development-for-neglected-tropical-diseases-through-partnerships
#14
Amy Starr, Katy M Graef, Jennifer Dent
Neglected tropical diseases are a group of infectious diseases that threaten and impact a significant portion of individuals living in low- and middle-income countries. Healthcare product R&D, which has been relatively limited for this group of infectious diseases, is timely and requires significant risk and resource investment by companies. Regardless of these costs, the global community has recognized the impact on human health that developing products for these diseases could have. Incentives, including 'push' and 'pull' funding, and platforms that support sharing of intellectual property through partnerships, such as The World Intellectual Property Organization Re:Search, are driving R&D...
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27813443/validity-studies-enhancing-patent-searches
#15
Sophie Bergeron, James L Grant
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27805847/compulsory-licensing-of-patents-in-india
#16
Rahul Chaudhry
This article deals with compulsory licensing scenarios in India, provides a background of relevant provisions in the Patents Act and examines how these provisions are Trade-Related Aspects of Intellectual Property Rights compliant. This article further discusses the procedure followed by India in granting a compulsory license, provides an overview of compulsory license applications filed in India to date and judicial precedence regarding the same. This article also highlights how compulsory licensing is a great safeguard that balances the interests of the innovators and the public at large...
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27805846/patent-highlights-june-july-2016
#17
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27805479/compulsory-licenses-as-a-defense-in-pharmaceutical-and-biotech-patent-litigation
#18
EDITORIAL
Andreas von Falck
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27804787/pharmaceutical-patent-applications-in-freeze-drying
#19
REVIEW
Edmond Ekenlebie, Tomaž Einfalt, Arianna Irò Karytinos, Andrew Ingham
Injectable products are often the formulation of choice for new therapeutics; however, formulation in liquids often enhances degradation through hydrolysis. Thus, freeze-drying (lyophilization) is regularly used in pharmaceutical manufacture to reduce water activity. Here we examine its contribution to 'state of the art' and look at its future potential uses. A comprehensive search of patent databases was conducted to characterize the international patent landscape and trends in the use of freeze-drying. A total of 914 disclosures related to freeze-drying, lyophilization or drying of solid systems in pressures and temperatures equivalent to those of freeze-drying were considered over the period of 1992-2014...
September 2016: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/27804785/crowdsourcing-in-pharmaceutical-r-d-a-revolutionary-concept-or-nothing-new
#20
Chie Hoon Song
No abstract text is available yet for this article.
September 2016: Pharmaceutical Patent Analyst
journal
journal
47821
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"